Galls Essential oil Phenols Flavones Antioxidants A B S T R A C T Essential oils of galled and non-galled leaves of Clusia lanceolata Cambess., Clusiaceae, were obtained by hydrodistillation and analyzed by GC and GC/MS. The chemical composition of both oils was similar, with a predominance of sesquiterpene caryophyllenes. The extracts from the leaves were evaluated regarding total phenols, flavonoids and proanthocyanidins. Galled leaves showed higher levels of phenolics and proanthocyanidins, since the content of flavonoids was higher in non-galled leaves. The chromatographic profiles of extracts were obtained by using HPLC/DAD and LC-ESI-MS. Electrospray ionisation (ESI) in positive and negative ion mode was used to identify four flavones C-glycosides in both extracts. The study constitutes a first report on the chemical research of C. lanceolata. The extract from galled leaves had a higher antioxidant activity.
Medicinal plants have long been used as an alternative to traditional drugs for the treatment of inflammatory conditions due to the classical side effects and restricted access of various commercially available drugs, such as steroids (GCs) and nonsteroidal anti-inflammatory drugs (NSAIDs). Sambucus australis is a Brazilian herb that is commonly used to treat inflammatory diseases; however, few studies have examined the use of this species in the treatment of inflammatory conditions. The present study aims to evaluate the potential anti-inflammatory activity of S. australis in vitro. We established spleen cell cultures stimulated with pokeweed mitogen (PWM) to evaluate the production of proinflammatory cytokines, such as Il-4, Il-5, IFN-y, and Il-10 (by elISA), and the expression of the transcription factor NF-kB (by RT-PCR). In addition, we evaluated the levels of nitric oxide in macrophage cultures and the membranestabilizing activity of S. australis methanolic extract (eMSA). Treatment with eMSA at concentrations of 100, 50, 25 and 12.5 µg/ml significantly decreased IL-4 (p<0.001) and IL-5 (p<0.001) levels. Treatment with 100 µg/ml EMSA reduced IFN-у (p<0.001) levels. Moreover, at 100 mg/ml, EMSA also increased IL-10 production and reduced NF-kB expression (p<0.01). In macrophage cultures stimulated with LPS, EMSA decreased nitric oxide levels (p<0.001) at all concentrations tested (100, 50, 25 and 12.5 µg/ ml). Additionally, EMSA had a protective effect in the erythrocyte membrane stabilization assay. Taken together, these results suggest that S. australis has anti-inflammatory potential in vitro, characterized by the reduction of both inflammatory cytokines and the expression of NF-kB along with the up-regulation of Il-10.
CHEMICAL CONSTITUENTS AND IN VIVO ANTIOXIDANT ACTIVITY OF FLAVONOIDS ISOLATED OF Clusia lanceolata (Clusiaceae). The phytochemical investigation of Clusia lanceolata leaves yielded fourteen compounds including six flavones, vitexin, isovitexin, isovitexin-2"-O-α-L-rhamnopyranoside, vitexin-2"-O-α-L-rhamnopyranoside, orientin and isoorientin, two phaeophytins [13²-hydroxy-(13²-S-)-phaeophytin a and 13²-hydroxy-(13²-R)-phaeophytin a], two triterpenes, α-and β-amyrin, and four steroids, β-sitosterol, stigmasterol, sitosterone and stigmasterone. Their structures were assigned based on spectroscopic analysis, including two-dimensional NMR techniques and comparison with literature data. The antioxidant capacity in vivo of vitexin and mixing isovitexin-2"-O-α-L-rhamnopyranoside and vitexin-2"-O-α-L-rhamnopyranoside was evaluated using the yeast Saccharomyces cerevisiae as the biological system model and hydrogen peroxide as a stressor agent. The results showed that the tested flavonoids were able to protect the yeast cell against the oxidative damage caused by H 2 O 2 .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.